Paediatric Dentistry and Orthodontics, Faculty of Dentistry, The University of Hong Kong, Prince Philip Dental Hospital, 34 Hospital Road, Sai Ying Pun, Hong Kong.
Department of Chemistry, Faculty of Science, CAS-HKU Joint Laboratory of Metallomics on Health and Environment, The University of Hong Kong, Pokfulam Road, Hong Kong.
Dent Mater. 2022 Jul;38(7):1149-1161. doi: 10.1016/j.dental.2022.05.002. Epub 2022 Jun 6.
To evaluate the inhibitory effect of a novel mussel-inspired monomer (N-(3,4-dihydroxyphenethyl)methacrylamide (DMA) on the soluble and matrix-bound proteases.
The inhibitory effect of DMA (0, 1, 5, and 10 mM) and 1 mM chlorhexidine (CHX) dissolved in 50% ethanol/water on soluble recombinant human matrix metalloproteinases (rhMMP-2, -8, and -9), as well as cysteine cathepsins (B and K) were evaluated using both fluorometric assay kits and molecular docking. The effect of CHX and DMA on matrix-bound proteases was examined by in situ zymography, and the fluorescence intensity and relative area were calculated by Image J software. All data obtained were analyzed by one-way ANOVA followed by Tukey test (α = 0.05).
The anti-proteolytic ability of DMA increased in a dose-dependent manner except that of rhMMP-9. Inhibitory effect of 1 mM DMA against rhMMP-2, - 8, - 9, as well as cathepsin B and K was all significantly lower than 1 mM CHX (p < 0.05). The molecular docking analysis was in good agreement with the experimental results, that the binding energy of DMA was lower than CHX for all proteases. In situ zymography revealed that all DMA- and CHX-treated groups significantly inactivated the matrix-bound proteases, with a dramatic reduction of the fluorescence intensity and relative area compared with the control group (p < 0.05).
Under the prerequisite condition that the overall inhibitory performance on matrix-bound proteases was comparable by DMA and CHX, the more selective property of DMA could avoid inducing potential negative effects by suppressing MMP-9 when applied in dental treatment compared with CHX.
评估一种新型贻贝启发单体(N-(3,4-二羟基苯乙基)丙烯酰胺(DMA)对可溶性和基质结合蛋白酶的抑制作用。
使用荧光分析试剂盒和分子对接,评估 DMA(0、1、5 和 10 mM)和 1 mM 氯己定(CHX)在 50%乙醇/水中对可溶性重组人基质金属蛋白酶(rhMMP-2、-8 和 -9)以及半胱氨酸组织蛋白酶(B 和 K)的抑制作用。通过原位酶谱法研究 CHX 和 DMA 对基质结合蛋白酶的影响,并用 Image J 软件计算荧光强度和相对面积。所有数据均采用单因素方差分析(α=0.05)进行分析。
DMA 的抗蛋白水解能力呈剂量依赖性增加,除 rhMMP-9 外。1 mM DMA 对 rhMMP-2、-8、-9 以及组织蛋白酶 B 和 K 的抑制作用均显著低于 1 mM CHX(p<0.05)。分子对接分析与实验结果一致,DMA 与所有蛋白酶的结合能均低于 CHX。原位酶谱法显示,DMA 和 CHX 处理组均能显著抑制基质结合蛋白酶,与对照组相比,荧光强度和相对面积均显著降低(p<0.05)。
在 DMA 和 CHX 对基质结合蛋白酶的整体抑制性能相当的前提下,DMA 的选择性更强,在牙科治疗中应用时,与 CHX 相比,能避免通过抑制 MMP-9 而产生潜在的负面影响。